Results 241 to 250 of about 284,364 (303)

Combined modality therapy

Current Opinion in Oncology, 1991
Encouraging results continue to emerge with the use of chemoradiotherapy. This review of the current literature demonstrates some of the advances that have been achieved in a variety of common malignancies with strategies based on well-defined rationales.
C J, McGinn, T J, Kinsella
openaire   +2 more sources

Combined modality therapy of esthesioneuroblastoma

Otolaryngology–Head and Neck Surgery, 2007
ObjectiveEsthesioneuroblastoma (ENB) is a rare tumor of the olfactory epithelium. The objective of this study was to evaluate treatment modalities including surgery, IMRT, and chemotherapy and patient outcomes.Patients and MethodsA retrospective analysis was performed on a total of 21 patients.
J Nicolas, McLean, Sunjay R, Nunley, Carmen, Klass, Charles, Moore, Susan, Müller, Peter A S, Johnstone   +5 more
openaire   +2 more sources

Combined modality therapy for esophageal cancer

Current Oncology Reports, 1999
Whereas many patients with esophageal carcinoma present with what appears to be localized disease, cure rates with surgical resection alone remain low. Although surgical resection, where feasible, affords patients the best chance of cure, the primary tumor has often invaded local tissues or structures, and occult micrometastases often exist at the time
Z, Gamliel, M J, Krasna
openaire   +2 more sources

Combination modality cancer therapy

International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988
Coordination compounds for use in therapy, the compounds having the general empirical formula [Rhm Xx Yy ]a in which m is the oxidation state of Rh, X is at least one anionic ligand, Y is at least one neutral ligand, with the proviso that at least one of X and Y is a nitrogen donor ligand, x is an integer from 1 to 6, y is an integer from 1 to 5 or may
Donald H Picker, Paul C Hydes
openaire   +1 more source

Combined Modality Therapy of Gastric Cancer

Surgical Oncology Clinics of North America, 1997
Most patients with adenocarcinoma of the stomach continue to present with advanced stages of disease. Although cure is not possible without complete resection, most patients will go on to recur and die of their disease. Despite the efforts of the last 3 to 4 decades, little progress has been made in improving disease specific survival.
M S, Karpeh, D P, Kelsen
openaire   +2 more sources

Combined modality therapy of esophageal carcinoma

Cancer, 1981
One hundred ten patients with epidermoid carcinoma of the esophagus were treated at the Memorial Sloan-Kettering Cancer Center (MSKCC) with combined modality techniques involving preoperative irradiation (RT) and surgery, and with preoperative chemotherapy (CT), surgery, and irradiation.
D P, Kelsen, R, Ahuja, S, Hopfan, M S, Bains, C, Kosloff, N, Martini, P, McCormack, R B, Golbey   +7 more
openaire   +2 more sources

Combined modality therapy for gynecologic cancer

Current Opinion in Oncology, 1995
The use of combined modality therapy in the primary management of gynecologic cancer continues to be explored. Although early ovarian cancer is treated with postoperative adjuvant treatment, the data to support its value is lacking. In advanced disease, paclitaxel has emerged as the most optimal treatment after maximal cytoreduction.
I, Ackerman, G M, Thomas
openaire   +2 more sources

Combined Modality Therapy

2014
Radiation therapy can be modified by increasing the effectiveness of radiation on tumors (radiosensitizers), protecting normal tissues (radioprotectors), increasing oxygen concentration, or by using systemic therapy drugs. Radio-protectors are described by their dose reduction factor (DRF) while radio-sensitizers are described by their enhancement ...
David S. Chang, Foster D. Lasley, Indra J. Das, Marc S. Mendonca, Joseph R. Dynlacht   +4 more
openaire   +1 more source

Combined modality therapy for pancreatic cancer

Seminars in Oncology, 2003
In spite of the high mortality in pancreatic cancer, significant progress is being made. This review discusses multimodality therapy for patients with pancreatic cancer. According to several phase II trials and Gastrointestinal Tumor Study Group results, improvements in locoregional control and survival may be achieved when chemotherapy is added to ...
James Y, Tsai, David A, Iannitti, Howard, Safran   +2 more
openaire   +2 more sources